Healthcare Services

A significant industry trend in the Fecal Transplant Therapy Market includes the Advancements In Microbiota-Based Therapeutics And Their Impact On Fetal Transplant Therapy

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Fecal Transplant Therapy Market From 2026 To 2030?

The fecal transplant therapy market size has shown strong expansion in recent years. It is forecast to increase from $2.15 billion in 2025 to $2.28 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.2%. The growth observed in the historical period can be attributed to the documented efficacy in recurrent cdi treatment, increasing hospital awareness of microbiome therapies, the expansion of gastroenterology specialty services, the availability of basic stool preparation technologies, and early-stage clinical trials.

The fecal transplant therapy market is anticipated to experience substantial expansion in the coming years. By 2030, its size is projected to reach $2.87 billion, demonstrating a compound annual growth rate (CAGR) of 5.9%. This growth throughout the forecast period is attributable to several factors, including the increasing variety of disease indications, a growing need for regulated and standardized products, the expansion of outpatient FMT procedures, rising investment in microbiome therapeutics, and improvements in automated stool processing systems. Key trends expected during this period involve the increasing clinical acceptance of stool-based therapies, the ongoing development of capsule and suspension formats, the expanding investigation into neurological and metabolic indications, the growth of in-hospital FMT programs, and a heightened focus on safety and standardization.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19431&type=smp

What Major Drivers Are Influencing Demand In The Fecal Transplant Therapy Market?

The increasing occurrence of inflammatory bowel disease is anticipated to boost the expansion of fecal transplant therapy markets. Inflammatory bowel disease (IBD) is characterized by persistent inflammation of the digestive tract, covering conditions like Crohn’s disease and ulcerative colitis. The surge in inflammatory bowel disease cases stems from factors such as increased intake of highly processed foods, frequent or inappropriate antibiotic administration, improved hygiene, and decreased exposure to infectious agents during childhood. Fecal transplant therapy aims to restore a healthy gut microbiota, which assists in mitigating inflammation and improving symptoms in individuals with inflammatory bowel disease, potentially influencing its management and progression. For instance, in June 2023, Crohn’s and Colitis Canada, a Canada-based non-profit organization, indicated that Canada is projected to have 470,000 inflammatory bowel disease (IBD) sufferers by 2035, a rise from an estimated 322,600 in 2023. Thus, the escalating prevalence of inflammatory bowel disease is propelling the growth of the fecal transplant therapy market.

Which Segments Are Included In The Analysis Of The Fecal Transplant Therapy Market?

The fecal transplant therapy market covered in this report is segmented –

1) By Procedure: Fecal Enema, Fecal Bacteriotherapy, Stool Transplant, Human Probiotic Infusion, Fecal Transfusion

2) By Disease: Clostridium Difficile Infection, Autism, Obesity, Parkinson’s Disease (PD), Diabetes Mellitus, Other Diseases

3) By End-User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Fecal Enema: Retention Enema, Cleansing Enema, Retention-Based Fecal Transplants, Home Administration Kits

2) By Fecal Bacteriotherapy: Suspension-Based Bacteriotherapy, Capsule Formulations, Customized Bacterial Preparations, Single Strain vs. Multi-Strain Products

3) By Stool Transplant: Direct Stool Transplant Procedures, Stool Suspension Transplant, Stool Capsule Transplant, Automated Stool Preparation Systems

4) By Human Probiotic Infusion: Single-Strain Probiotic Infusions, Multi-Strain Probiotic Infusions, Probiotic Blends With Prebiotics, Infusion Kits for Healthcare Providers

5) By Fecal Transfusion: Intravenous Fecal Transfusion, Transfusion via Gastrostomy Tube, Pre-Packaged Fecal Transfusion Solutions, Fecal Transfusion For Research Purposes

What Major Market Trends Are Driving Changes In The Fecal Transplant Therapy Market?

Leading companies in the fecal transplant therapy market are concentrating on developing innovative treatments, such as oral pill forms of fecal microbiota transplantation (FMT) therapy, to improve patient compliance and broaden the therapy’s accessibility. This pill form of fecal microbiota transplantation (FMT) therapy comprises encapsulated live bacteria from donor feces, intended for oral consumption. Its goal is to replenish healthy gut bacteria and foster better intestinal health. For example, in April 2023, Seres Therapeutics Inc., a US-based biotechnology company, and Nestlé Health Science S.A., a Switzerland-based healthcare company, introduced VOWST. Supplied in capsule form, it offers a convenient and less invasive treatment option for preventing recurrent clostridioides difficile infection (rCDI) in adults after antibacterial treatment. Unlike traditional fecal microbiota transplantation (FMT), which involves transferring whole stools, VOWST employs live bacterial spores of multiple Firmicute species, sourced from the fecal microbiota of healthy human donors, believed to restore the gut microbiome.

Which Key Industry Participants Are Active In The Fecal Transplant Therapy Market?

Major companies operating in the fecal transplant therapy market are Mayo Clinic, Mount Sinai Health System Inc., Northwestern Medicine, NYU Langone Health, Michigan Medicine, UCLA Health, Duke University Health System Inc., Stanford Health Care, Ferring Pharmaceuticals, Cincinnati Children’s Hospital Medical Center, Emory Healthcare, Cambridge University Hospitals NHS Foundation Trust, Hamilton Health Sciences Corporation, Brigham and Women’s Faulkner Hospital Inc., Rebiotix Inc., Seres Therapeutics Inc., UPMC Hillman Cancer Center, OpenBiome, Center for Digestive Disease, BiomeBank Incorporated, The Regents of the University of California

Read the full fecal transplant therapy market report here:

https://www.thebusinessresearchcompany.com/report/fecal-transplant-therapy-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Fecal Transplant Therapy Market?

North America was the largest region in the fecal transplant therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fecal transplant therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Fecal Transplant Therapy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19431&type=smp

Browse Through More Reports Similar to the Global Fecal Transplant Therapy Market 2026, By The Business Research Company

Genes Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Oligonucleotides Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report

Stem Cells Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795